After China's entry into WTO, New Australia International Pharmaceutical Company quickly and comprehensively entered the Asia-Pacific region, and chose Longli International (Hong Kong) Health Pharmaceutical Co., Ltd., which has a huge sales network, as a strategic alliance to be responsible for the production, promotion and after-sales service in the Asia-Pacific region and China region.
In order to ensure the timely and sufficient supply of products and meet the huge demand in the domestic market, Xinao International Pharmaceutical Company successfully acquired Guangzhou Green Valley Health Products Factory as the production base of China District 1, and then built a large-scale modern production base of No.2 in China District in Panyu District, Guangzhou, becoming the only health food manufacturer with two GMP factories in Guangzhou, a megacity in China. The base has a GMP standard workshop of nearly 10,000 square meters, advanced imported equipment, testing instruments and professional technicians, and implements HACCP (Hazard Analysis and Critical Control) system to provide sufficient supply for the domestic market, while ensuring that each bottle of products has undergone strict quality control and has the best safety.